Ossiam Acquires 2,241 Shares of Teleflex Incorporated (NYSE:TFX)

Ossiam raised its holdings in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 150.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,730 shares of the medical technology company’s stock after purchasing an additional 2,241 shares during the quarter. Ossiam’s holdings in Teleflex were worth $664,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Vontobel Holding Ltd. lifted its holdings in Teleflex by 21.9% during the 4th quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company’s stock valued at $248,000 after buying an additional 250 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Teleflex by 14.3% during the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock valued at $38,374,000 after acquiring an additional 19,466 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Teleflex by 5.2% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock valued at $19,263,000 after acquiring an additional 5,322 shares in the last quarter. Lecap Asset Management Ltd. purchased a new stake in shares of Teleflex in the fourth quarter valued at approximately $729,000. Finally, Mirae Asset Global Investments Co. Ltd. grew its stake in Teleflex by 35.1% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock worth $1,053,000 after purchasing an additional 1,527 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

TFX has been the subject of a number of research analyst reports. Wells Fargo & Company decreased their target price on Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th. Piper Sandler reiterated a “neutral” rating and set a $140.00 target price (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. Bank of America lowered shares of Teleflex from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $235.00 to $140.00 in a report on Tuesday, March 4th. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Finally, Truist Financial dropped their target price on Teleflex from $149.00 to $140.00 and set a “hold” rating on the stock in a research report on Friday, April 11th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $169.63.

Check Out Our Latest Research Report on TFX

Teleflex Stock Performance

Shares of Teleflex stock opened at $129.33 on Tuesday. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 52 week low of $124.66 and a 52 week high of $249.91. The firm has a market capitalization of $6.00 billion, a P/E ratio of 25.71, a PEG ratio of 1.73 and a beta of 1.19. The company has a 50 day moving average price of $142.90 and a 200 day moving average price of $176.30.

Teleflex (NYSE:TFXGet Free Report) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Sell-side analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.05%. Teleflex’s dividend payout ratio (DPR) is presently 95.77%.

About Teleflex

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Further Reading

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.